Protective effect of Mumiju against acetic acid-induced ulcerative colitis in rats. 2018

Nadar Shahrokhi, and Zakieh Keshavarzi, and Mohammad Khaksari Haddad, and Fereshteh Amirafzali, and Shahriar Dabiri, and Nava Shahrokhi
Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.

OBJECTIVE In this study, we elucidated the ameliorative effect of aqueous extract of leaves of Mumiju against acetic acid-induced experimental colitis in male rats. METHODS The animals were randomly divided into four groups (n=7) including I: control group, II: vehicle group (injected with 2 ml acetic acid (4%) intra rectally), III and IV: treatment groups which received Mumiju (250 mg/kg) orally or intraperitoneally for 4 consecutive days after ulcer induction. Ulcer index, severity of inflammation, colonic levels of superoxide dismutase (SOD), glutathione (GSH), and malondialdehyde (MDA), and histological changes were recorded after the treatment regimen of 4 days. RESULTS The ulcer index, severity of inflammation and colonic MDA levels were increased following intrarectal instillation of acetic acid. Also, acetic acid significantly decreased the SOD and GSH levels. Treatment with Mumiju for 4 days exhibited significantly lowered oxidative stress, while elevated of SOD and GSH levels. Regenerative-healing patterns also was seen by histopathological findings after treatment with Mumiju. CONCLUSIONS The present investigation demonstrates that Mumiju could be regarded as a herb with potent therapeutic value in the amelioration of experimental colitis in laboratory animals by modulation of oxidant- antioxidant system.

UI MeSH Term Description Entries

Related Publications

Nadar Shahrokhi, and Zakieh Keshavarzi, and Mohammad Khaksari Haddad, and Fereshteh Amirafzali, and Shahriar Dabiri, and Nava Shahrokhi
April 2017, Pharmacological reports : PR,
Nadar Shahrokhi, and Zakieh Keshavarzi, and Mohammad Khaksari Haddad, and Fereshteh Amirafzali, and Shahriar Dabiri, and Nava Shahrokhi
March 2011, European journal of pharmacology,
Nadar Shahrokhi, and Zakieh Keshavarzi, and Mohammad Khaksari Haddad, and Fereshteh Amirafzali, and Shahriar Dabiri, and Nava Shahrokhi
March 2013, Toxicology and applied pharmacology,
Nadar Shahrokhi, and Zakieh Keshavarzi, and Mohammad Khaksari Haddad, and Fereshteh Amirafzali, and Shahriar Dabiri, and Nava Shahrokhi
September 2013, World journal of gastroenterology,
Nadar Shahrokhi, and Zakieh Keshavarzi, and Mohammad Khaksari Haddad, and Fereshteh Amirafzali, and Shahriar Dabiri, and Nava Shahrokhi
January 2021, BMC complementary medicine and therapies,
Nadar Shahrokhi, and Zakieh Keshavarzi, and Mohammad Khaksari Haddad, and Fereshteh Amirafzali, and Shahriar Dabiri, and Nava Shahrokhi
December 2021, International immunopharmacology,
Nadar Shahrokhi, and Zakieh Keshavarzi, and Mohammad Khaksari Haddad, and Fereshteh Amirafzali, and Shahriar Dabiri, and Nava Shahrokhi
January 2002, Tropical gastroenterology : official journal of the Digestive Diseases Foundation,
Nadar Shahrokhi, and Zakieh Keshavarzi, and Mohammad Khaksari Haddad, and Fereshteh Amirafzali, and Shahriar Dabiri, and Nava Shahrokhi
February 2021, BMC complementary medicine and therapies,
Nadar Shahrokhi, and Zakieh Keshavarzi, and Mohammad Khaksari Haddad, and Fereshteh Amirafzali, and Shahriar Dabiri, and Nava Shahrokhi
August 2017, The Journal of surgical research,
Nadar Shahrokhi, and Zakieh Keshavarzi, and Mohammad Khaksari Haddad, and Fereshteh Amirafzali, and Shahriar Dabiri, and Nava Shahrokhi
October 2016, Journal of evidence-based complementary & alternative medicine,
Copied contents to your clipboard!